Evidence for the role of AP dysregulation in C3 glomerulopathy is drawn from linkage studies in a small number of pedigrees, cohort studies showing an association with C3NeFs and complement regulatory gene variants, and animal models. This evidence concerns the gene DHCR7-DT and complement 3 glomerulopathy.